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Abstract  
Aims: The aim of this study was to improve production of pentaene 32,33-didehydroroflamycoin 
(DDHR) in Streptomyces durmitorensis MS405 strain in order to obtain quantities sufficient for 
in depth analysis of antimicrobial properties. 
Methods and Results: Through classical medium optimization conditions for stable growth, 
DDHR production within 7 days of incubation was established.  Yields of 215 mg l-1 were 
achieved in shake flask experiments in complex medium with mannitol as the primary carbon 
source.  DDHR had poor antibacterial activity with minimal inhibitory concentrations (MIC) of 
400 μg ml-1 for Staphylococcus aureus and Bacillus subtilis, while MIC of 70 μg ml-1 was 
determined for Candida albicans.  Using flow cytometry and fluorescent microscopy it was 
demonstrated that DDHR induced membrane damage in C. albicans followed by cell death.  
Combination studies with known antifungal nystatin showed that DDHR is a promising agent for 
the development of novel antimycotic treatments potentially less toxic for human cells. 
Conclusions: Pentaene didehydroroflamycoin has no antibacterial activity but can be further 
developed for the application in antifungal therapy. 
Significance and Impact of the Study: This study is the first report on the stable and production 
in high yields of a novel pentaene family that acts on Candida cell membranes and can be used 
in combination with known antifungals.  Polyenes are still antifungal antibiotics of choice and 
therefore isolation and production of new lead structures is highly significant. 
 
Introduction 
Polyene macrolides are a group of bioactive molecules with large macrolactone rings 
containing a series of 3 to 8 conjugated double bonds (Omura and Tanaka 1984).  They are 
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synthetized via repetitive enzymatic condensation of small carboxylic acids by the 
multifunctional enzymes polyketide synthases usually as secondary metabolites of Streptomyces 
strains (Aparicio et al. 2003; Fischbach and Walsh 2006).  Polyenes were the first agents used in 
antifungal therapy (Juan and McDaniel 1977) and were shown to have a broad spectrum of 
antifungal activity with low frequency of resistant pathogen appearance (Ghannoum and Rice 
1999).  To date more than 200 polyene macrolides have been discovered and traditionally have 
been considered as potential antifungal agents (Zotchev 2003).  Only a few antifungals are 
currently being used in human therapy including amphotericin B, nystatin, candicidin, pimaricin, 
methyl partricin and trichomycin (Zotchev 2003).  Polyene macrolides interact with sterols in the 
cell membrane usually forming barrel shaped structured pores making it permeable to ions and 
other small molecules (Bolard 1986; Milhaud 1992; Cohen 2010).  Low water solubility and 
interactions with cholesterol in mammalian cell membranes are accountable for their poor tissue 
distribution, severe side effects and high toxicity (Recamier et al. 2010; Rimaroli et al. 2002; 
Wasko et al. 2012).  Despite all drawbacks, polyene macrolides make up one of the most 
important classes of systemic antifungals and efforts are continuously made towards obtaining 
new, safer, and improved broad-spectrum antifungal polyene agents (Georgopapadakou 1998; 
Ostrosky-Zeichner et al. 2010; Zotchev 2003).  
Due to their complex chemical structure, polyene antibiotics that are in current clinical use 
are produced by microbial fermentations (Lemke et al. 2005; Jonsbu 2001).  For amphotericin B 
and nystatin patents for production in biotechnological processes issued in 1950-es with some 
improvement are still the main source points for the production on an industrial scale (Dutcher et 
al. 1959; Schaffner and Kientzler 2000; Hazen and Brown 1957).  Recently, a novel polyketide 
pentaene macrolide family with the predominant member 32,32-didehydroroflamycoin (DDHR; 
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Fig. 1a), produced by Streptomyces durmitorensis MS405T, has been described (Stodulkova et 
al. 2011).  Its cell toxicity was established on the various human and mouse carcinoma cell lines 
(Stodulkova et al. 2011).  However, due to the poor and unstable production and limited amounts 
of the metabolite available, DDHR potential as an antibacterial and antifungal agent has not been 
examined.  Thus, we were set to optimize production conditions for DDHR and to evaluate its 
antibacterial and antifungal activity, as well as to establish its hemolytic activity and cytotoxicity 
on non-cancer cell lines. 
 
Materials and methods 
Streptomyces durmitorensis MS405 maintenance and culture conditions for DDHR 
production 
Streptomyces durmitorensis MS405 strain (DSM 41863) (Savic et al. 2007) was maintained on 
solid mannitol soy flour medium (MSF) (Kieser et al. 2000).  Plates were incubated at 30ºC for 7 
days and spore suspension was made.  S. durmitorensis MS405 spore suspensions were stored in 
glycerol (20%, v/v), maintained at -80ºC and used for the inoculation of cultures for further 
experiments (Kieser et al. 2000).  Spore suspensions (20 µl) were firstly inoculated into tryptone 
soy broth (TSB) (25 ml; tryptone soy broth powder, 30 g l-1) and incubated at 30ºC for 48 h, and 
this pre-culture was washed with PBS and then used for the inoculation of different media (1%, 
v/v).  For the DDHR production, cultures were grown in Erlenmeyer flasks (1:5 culture to 
volume ratio) containing coiled stainless steel spring for better aeration, and unless otherwise 
stated incubated in dark at 30ºC on a rotary shaker (200 rpm) for 7 days.  Unless otherwise 
stated, all media components were purchased either from Oxoid (Cambridge, UK), Becton 
Dickinson (Sparks, MD, USA) or Sigma Aldrich (Munich, Germany). 
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Composition and preparation of the media for optimization of the DDHR production 
Five different complex media were tested for the growth and accumulation of DDHR by S. 
durmitorensis MS405.  Complex media included in this study were: NEM (glucose, 10 g l-1; 
yeast extract, 20 g l-1; beef extract powder, 1 g l-1; casamino acids, 2 g l-1 and mannitol, 20 g l-1); 
JS (glucose, 20 g l-1; soluble starch, 20 g l-1 (Merck, Darmstadt, Germany); mannitol, 15 g l-1; 
soy flour, 30 g l-1 (Florida Bel, Serbia); CaCO3, 10 g l-1; MSF (soy flour, 20 g l-1; mannitol, 20 g 
l-1; in tap water; GYM (glucose, 4 g l-1; yeast extract, 4 g l-1; malt extract, 10 g l-1); YED 
(glucose, 50 g l-1; bacto peptone , 10 g l-1; CaCO3, 10 g l-1; MnCl2, 0.01 g l-1; FeSO4, 0.01 g l-1. 
NEM medium was optimized by subtraction of various media components such as sugars and 
nitrogen sources and combinations thereof, supplementation of methyl oleate (0.2 %, v/v) and 
grape seed oil (0.2 %, v/v), substitution of carbon sources with equimolar carbon amount of 
glucose (29.8 g l-1), mannitol (30.1 g l-1), glycerol (24.1 ml l-1), arginine (28.8 g l-1), sodium 
succinate (67 g l-1), and methyl oleate (18 ml l-1), and substitution of nitrogen sources with 
sodium nitrate (3 g l-1) (Table 2).  The pH of the media was adjusted to 7.2 before sterilization.  
Media were sterilized at 121ºC for 15 min. 
 
Monitoring of DDHR production, purification and quantification 
To monitor DDHR production, 3 ml culture aliquots were taken at different time points and 
extracted with 2 ml of ethyl acetate.  To isolate DDHR, 50 ml cultures were extracted using ethyl 
acetate (2 x 50 ml) by vigorous mixing at room temperature (1 h).  Ethyl acetate extract was 
separated from aqueous phase and the cell debris by centrifugation (5000 g for 3 min at 4ºC; 
Eppendorf 5804R bench top centrifuge).  The wave length scan of the extract was done from 200 
to 700 nm using UV/Visible spectrophotometer Ultrospec 3300pro (Biochrom, Cambridge, UK).  
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In order to purify DDHR, the DDHR containing ethyl acetate fraction was then dried with 
Na2SO4, followed by drying under vacuo.  This crude culture extract was further purified by 
flash chromatography.  Flash chromatography employed silica gel 60 (230-400 mesh), while 
collected fractions were analysed by thin layer chromatography using alumina plates with 0.25 
mm silica layer (Kieselgel 60 F254, Merck; ethyl acetate: MeOH (8:2) solvent system for 
development) and by UV-Vis spectral analysis.  The following solvent system was used for the 
fractionation of 120-200 mg of ethyl acetate extract: ethyl acetate (150 ml), ethyl acetate and 
methanol (8:2 ratio, 150 ml), followed by ethyl acetate and methanol (1:1 ratio, 60 ml).  
Appropriate fractions were combined, dried under vacuo and weighed.  To determine relative 
distribution of DDHR between mycelia and culture broth, ethyl acetate extraction was carried out 
on the cell pellet and the supernatant separately. 
 
The purified DDHR was resolved and identified by liquid chromatography coupled by mass 
spectroscopy (LC-MS) analysis.  The HPLC analysis was performed on a Agilent 1200 Series 
(Agilent Technologies, Santa Clara, CA, USA) with a Zorbax Extend C18 column (RRHT, 150 
× 4.6 mm i.d.; 1.8 μm) and a diode-array detector (DAD), coupled with a 6210 time-of-flight 
LC/MS system (Agilent Technologies).  The column temperature was 40°C with a constant flow 
rate of 0.5 ml min-1.  The mobile phase was a gradient prepared from 0.2% formic acid in water 
(A) and acetonitrile (B), according to the following program: 0-0.24 min, 5% B; 0.24-10 min 5-
95% B; 10-15 min 95% B; 15-15.5 min 95-5% B; 15-18.5 min 5% B. High resolution ESI MS 
spectra were recorded in the range m/z 100–2500 in positive and negative ion mode, with 4000V 
ion source potential and 140V  of fragmentor potential. 
 
A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved. 
Cell dry weight determination 
Culture samples of 3 ml were taken in triplicate from the culture upon inoculation and every 24 h 
during 7 days cultivation period.  Culture samples were centrifuged at 5000 g for 5 min at 
ambient temperature (Eppendorf 5804R bench top centrifuge), dried for 24 h at 65°C and 
weighted on analytical scale (Sartorius, Göttingen, Germany). 
 
Antimicrobial assays 
Test organisms for the antibacterial assays were obtained from the American Type Culture 
Collection (ATCC) and National Collection of Type Cultures (NCTC).  They included: Bacillus 
subtilis (ATCC 6633), Enterococcus faecalis (ATCC 29212), Escherichia coli (NCTC 9001), 
Klebsiella pneumoniae (ATCC 13883), Listeria monocytogenes (NCTC 11994), Micrococcus 
luteus (ATCC 379), Pseudomonas aeruginosa (ATCC 27853), Salmonella typhimurium (NCTC 
12023), Staphylococcus aureus (ATCC 25923) and Candida albicans (ATCC 10231). 
 
Standard disc diffusion assay was done for the preliminary screen using DDHR in dimethyl 
sulfoxide (DMSO).  Briefly, late stationary phase cells of test microorganisms were diluted to 
OD600=0.1 and spread on agar plates (250 µl), LB (Sambrook 1989) for bacteria and Sabouraud 
dextrose agar (glucose 40 g l-1; peptone, 10 g l-1; agar, 15 g l-1; pH 5.6) for Candida.  Sterile 
paper discs (HiMedia Laboratories, Mumbai, India) were applied to the plate surface.  Several 
concentrations of DDHR in DMSO were applied per disc (10 µg, 50 µg, 100 µg, 500 µg and 1 
mg) and the same volume of the solvent was used as a control.  As a positive control, nystatin 
powder (Hemofarm, Vrsac, Serbia) in amounts of 5 µg, 10 µg, and 50 µg in DMSO were applied 
per disc.  Plates were incubated at 30°C for 24 h, and zones of inhibition were measured. 
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The minimum inhibitory concentration (MIC) of DDHR was studied using a referent method 
for testing antimicrobial agents (EUCAST 2003) in 96-well microtiter plate assay.  The assay 
allowed bacterial growth at 30oC and its inhibition to be assessed over time.  A dilution series of 
DDHR were prepared in DMSO.  Controls containing solvent were carried out in each assay.  
MIC was defined as the lowest concentration of compound at which no evidence of growth was 
observed. 
 
Fluorescence microscopy and flow cytometry 
Candida albicans cell suspension (OD660=1) was treated with DDHR (25, 50 or 100 μg ml-1), 
nystatin (5, 10 or 50 μg ml-1) or combination of the two drugs (DDHR 25 μg ml-1 and nystatin 5 
μg ml-1) for 2 h at 30°C.  Following treatment, cells were washed with PBS and stained with 
propidium iodide (PI, 100 μg ml-1; Sigma) in the dark for 30 min at 4°C.  The cells were 
subsequently counter stained with 1 μg ml-1 DAPI (4',6-diamidino-2-phenylindole; Sigma).  
After washing with PBS, 15 μl aliquots of cell suspension were transferred to a microscope 
slides, observed under Olympus BX51 fluorescent microscope and analyzed with Cytovision 3.1 
software (Applied Imaging Corp., San Jose, USA).  Aliquots of PI stained cells were washed 
twice with PBS and the number of cells with damaged membranes was determined using flow 
cytometry on FACS Calibur (BD Biosciences, Oxford, UK) and the results were analyzed using 
CellQuestPro software (BD Biosciences, Oxford, UK). 
 
Hemolysis assay 
Sheep red blood cells in PBS (1% v/v, Torlak, Belgrade, Serbia) were treated for 1 h with 1, 10 
or 50 μg ml-1 of DDHR at 37°C.  Hemoglobin absorbance was measured at 405 nm (plate reader 
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Labsystem Multiscan RC, MTX Labsystems Inc., Vienna, WY, USA).  The hemolysis 
percentage was calculated using the following equation: hemolysis (%) = 100[(Abs405nm (treated) 
- Abs405nm (non treated) / (Abs405nm (0.1% Triton X-100 lysed) - Abs405nm (non treated)]. 
 
Cytotoxicity assay  
MRC5 cell line (human lung fibroblast, obtained from ATCC) were grown in humidified 
atmosphere of 95% air and 5% CO2 at 37°C and maintained as monolayer cultures in RPMI-
1640 supplemented with 100 μg ml-1 streptomycin, 100 U ml-1 penicillin, and 10% (v/v) fetal 
bovine serum (FBS) (all from Sigma, Munich, Germany).  MRC5 cells were treated with 
increasing concentrations (6.25, 12.5, 25, 50 or 100 μg ml-1) of DDHR or nystatin for 48 h and 
cytotoxicity was determined using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide 
(MTT) reduction assay (Hansen et al. 1989).  Upon treatment, MTT (Sigma, Munich, Germany) 
(0.5 mg ml-1) was added to each well and incubated for 1 h, and then the supernatants were 
discarded.  To dissolve the dye precipitate DMSO (50 µl) was added to each well and oscillated 
for 15 s.  Absorbance was measured at 490 nm on plate reader (MTX Labsystems Inc., Vienna, 
WY, USA).  The MTT viability assay was performed two times in five replicates. 
 
Results 
DDHR production by S. durmitorensis MS405 in submerged cultures 
All five complex media supported S. durmitorensis MS405 growth in submerged cultures to 
different levels.  The highest biomass yield was achieved in the JS medium and was from 2.2- to 
7.3-fold higher in comparison to other media used (Table 1).  On the other hand, characteristic 
‘three fingers’-like profile of polyene UV-Vis absorption spectrum was observed in ethyl acetate 
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extracts of culture grown in three media, namely JS, MSF and NEM (Fig. 1 b).  The absorption 
spectra were in good correlation with previously reported maxima at 260 nm, 363 nm and a 
shoulder at 375 nm (Stodulkova et al. 2011).  Upon purification using flash chromatography, 
polyene-containing fraction was analyzed by liquid chromatography followed by tandem mass 
spectroscopy (LC-MS), and it was confirmed that major product of the polyene family was 
DDHR (Fig. 1 a; Supplementary Fig. S1).  Indeed, the highest overall yields of DDHR polyene 
were obtained in NEM medium and were 1.8- and 1.9-fold higher in comparison to MSF and JS 
cultures respectively, while no polyene production was detected in GYM and YED media under 
conditions tested (Table 1).  DDHR was distributed between mycelia and culture broth in 3 to 1 
ratio (data not shown), thus the productivity of DDHR per mg of cell dry weight was 3.3- and 
7.7-fold higher in NEM medium in comparison to MSF and JS respectively (Table 1), and this 
medium was selected for further production optimizations. 
 
Considering the high variation in DDHR production amongst five media, we have firstly 
examined the effect of carbon source on biomass and DDHR production (Table 2).  As total 
carbon content in NEM medium was 12 g l-1 (4 g from glucose and 8 g from mannitol), we have 
kept the carbon content at the same level and varied 6 different C-sources including glycerol, 
sodium succinate, methyl oleate and arginine (Table 2).  All six C-sources supported S. 
durmitorensis MS405 growth, while DDHR was not detected in cultures containing sodium 
succinate and arginine as primary C-source.  The highest levels of biomass achieved were when 
methyl oleate was used as primary C-source and was 1.2- to 2.7-fold higher in comparison to all 
other C-sources tested (Table 2).  Glucose as the primary C-source supported the lowest biomass 
yields, and the lowest DDHR production that was 9.4-fold lower in comparison to the culture 
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when mannitol was the primary C-source (Table 2).  However, mannitol as the primary C-source 
supported good growth, the highest DDHR overall yield and the production rates that were from 
1.3- to 4-fold higher in comparison to all other C-sources (Table 2).  Surprisingly, the methyl 
oleate as the primary C-source supported comparable biomass and DDHR overall yields to 
mannitol. 
 
The effect of various NEM medium components on DDHR production was further examined 
by subtraction of different components and by supplementation with methyl oleate and grape 
seed oil (Table 3).  Generally, subtraction of different media components resulted in decreased 
biomass and DDHR production.  The highest biomass decrease of 1.8-fold in comparison to 
original NEM medium was observed when mannitol was not included in the medium.  The 
DDHR was not detected in cultures when mannitol and yeast extracts were omitted, while 
decreased levels of 1.7- to 2.1-fold of DDHR were obtained when glucose, meat extract and 
casamino acids were not included in the medium (Table 3).  Addition of methyl oleate and grape 
seed oil as supplements to the NEM medium resulted in 2.3- and 1.7-fold higher biomass yields 
respectively, while DDHR overall yields were not or only slightly changed in comparison to 
original NEM medium, resulting in 2.4- and 1.5-fold decrease in DDHR productivity per mg of 
cell dry weight (Table 3). 
 
Antibacterial activity of DDHR 
Purified DDHR had antibacterial properties against S. aureus, B. subtilis, E. faecalis, M. luteus 
and K. pneumonie, with zones of growth inhibition of 20, 14, 13, 9 and 8 mm in diameter 
respectively when 1 mg of DDHR was applied to the discs.  No zones of growth inhibition 
A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved. 
occured when E. coli, L. monocytogenes, P.aeruginosa and S. typhimirium were used as test 
organisms (Fig. 2).  All tested strains were sensitive to the known antibiotic kanamycin and in all 
cases, DMSO was used as a vehicle solvent and as a negative control. 
The MICs, defined as minimal concentrations at which no growth occurred in liquid culture, 
were determined for the test organisms that showed zones of growth inhibition in disc difussion 
screen (Fig. 2).  The antibacterial activity of DDHR was poor, with MICs of 400 μg ml-1 for S. 
aureus and B. subtilis and MICs > 1 mg ml-1 for other tested bacterial strains. 
 
DDHR activity against Candida albicans and effect on cellular membrane 
The disc diffusion assay on Candida albicans with 100 μg of DDHR applied per disc gave 15 
mm zones of growth inhibition, while MIC determined in liquid culture was 70 μg ml-1.  
Nystatin which had a MIC of 10 µg ml-1 was used as a control. 
As macrolide polyenes are well known to bind and disturb membranes, we studied the effect 
of purified DDHR on the membrane integrity of sheep red blood cells.  We monitored the release 
of hemoglobin from RBCs treated with increasing concentrations of DDHR and showed that 
DDHR induces dose dependent hemolysis with 75% cells lysed at DDHR concentration of 50 μg 
ml-1 (Fig. 3 a).  Next we examined the effect of DDHR on C. albicans membranes by the 
combined PI/DAPI cell staining assay.  PI is membrane impermeable dye and binds to nucleic 
acid only in the dead cells yielding fluorescence in the red wavelength region.  DAPI easily 
passes the membrane and strongly binds to DNA of both living and dead cells.  We treated C. 
albicans with DDHR doses below (50 μg ml-1) and above (100 μg ml-1) MIC concentration and 
showed that treatment with doses higher than MIC induced the membrane damage and cell death 
(Fig. 3 b).  Candida cells treated with 5 or 10 μg ml-1 of nystatin had intact membranes although 
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the cell death was visible according to brightly stained condensed nuclei indicating apoptosis 
(Fig. 3 c). 
The number of PI positive Candida cells treated with DDHR or nystatin was determined by 
flow cytometry.  DDHR treatment above MIC concentration (100 μg ml-1) induced the 
membrane damage in 80% of treated cells, while nystatin treatment resulted in only 10% cells 
with disintegrated membranes (Fig. 3 c).  These results suggested that toxic activity of DDHR 
differs from nystatin which is known to induce cell death by forming transient pores in the 
membranes of C. albicans (Bolard 1986; Recamier et al. 2010).  Therefore, we examined the 
effect of two polyenes on Candida cells in combination (Fig. 4).  Concentrations of 25 µg per 
disc of DDHR or 5 µg per disc of nystatin preparation separately showed neither growth 
inhibition zone, nor membrane damage and cytotoxicity on C. albicans (Fig. 4 a and Fig. 4 b).  
However, when applied in combination they caused the growth inhibition and the membrane 
disintegration as demonstrated by PI positive cells with condensed nuclei (Fig. 4 c). 
 
Cytotoxicity of DDHR to human cells 
To address the suitability of DDHR for the treatments of candidemia in humans we finally 
examined its cytotoxicity to human cells.  DDHR killed HTR-8/SVneo human trophoblast cell 
line (Graham et al. 1993), although less efficiently with the IC50 of 1 mM determined after 1 h 
of treatment (data not shown).  We treated fibroblast cell line MRC5 with increasing 
concentrations of DDHR and observed cell viability after 48 h of treatment using MTT assay. 
DDHR induced fibroblast death only when the doses above Candidida MIC concentration were 
applied (Fig. 5).  Candida MIC concentrations for nystatin nystatin (> 10 mg ml-1) did not have 
any toxic effect on MRC5 cells.  
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Discussion 
From early on, since their discovery it was noticed that production of polyene antibiotics in 
Streptomyces greatly depended on media composition and cultivation conditions (Jonsbu et al. 
2000; Jonsbu et al. 2002; Martin et al. 2011; Martin and McDaniel 1977).  Indeed, from our 
experience with S. durmitorenis MS405 it took a considerable period of time after the strain 
isolation and bioactive compound exhibiting activity on Saccharomyces cerevisiae FAV20 strain 
was detected on solid media (Savic et al. 2007) that the structure of the bioactive compound was 
elucidated and limited activity shown (Stodulkova et al. 2011).  This was due mainly to unsteady 
growth and production of the compound in submerged culture.  Therefore, the first objective of 
this study was to establish submerged culture conditions to allow high and steady pentaene 
macrolide DDHR family production in this strain in order to obtain sufficient material for further 
activity tests. 
 
S. durmitorensis MS405 grew poorly in minimal media and in liquid media widely used as 
standard for propagation of soil actinomyces such as R2, YEME or TSB (Kieser et al. 2000).  It 
usually took 28 days of incubation in TSB medium supplemented with mannitol for the 
production of DDHR (Stodulkova et al. 2011).  In this study, growth and DDHR production 
were tested in five complex nutrient-rich media (Table 1).  In the JS or MSF medium, containing 
complex nutrients as soy flour, soluble starch and mannitol, high biomass and production of 
DDHR was achieved even after 5 days incubation, while in more defined media such as GYM or 
YED containing glucose and yeast extract or peptone, biomass yields were 5-7 folds lower with 
no polyene production (Table 1).  However, the medium that stood out for the highest 
reproducibility of the both biomass and DDHR yields was between the two groups, containing 
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yeast extract, beef extract, casamino acids, glucose and mannitol (NEM).  The synthesis of 
DDHR was highly dependent on the presence of mannitol in the medium. 
The amount and type of carbon source dependency for growth and bioactive compounds 
production in Streptomyces is not unusual, and appears that special nutrition requirements are the 
rule rather than the exception in polyene production by Streptomyces (Jonsbu et al. 2000; Jonsbu 
et al. 2002; Liu et al. 1975).  Of all tested carbon sources mannitol and methyl oleate gave 
equally high production of DDHR, whereas use of glycerol and glucose gave significantly lower 
yields of 3.4- and 9-folds, respectively.  Substances with long aliphatic chain such as methyl 
oleate had previously been used as the supplement for the improvement of other polyketide 
yields (Frykman et al. 2005), and other pentaenes, namely filipin III (Brock 1956).  
 
Overall yields of DDHR were 50-fold higher in comparison to similar shake flask 
cultivations of Streptomyces filipinensis for filipin III production (Brock 1956), or Streptomyces 
nodosus ATCC14899 for amphotericin B production (Nikodinovic 2004).  Yields obtained in 
this study were about 3-fold higher in comparison to yields of tetraene nystatin obtained in batch 
fermentation (Jonsbu et al. 2001; Jonsbu et al. 2002) and about 2-fold higher in comparison to 
amounts of heptaene trichomycin B obtained from the fermentor cultivation (Komori 1990).  
However, DDHR yields were 15- to 20-folds lower in comparison to industrial scale production 
yields reported for heptaenes amphotericin B and candicidin, respectively (Dutcher et al. 1959; 
Gil et al. 1985; Liu et al. 1975; McNamara et al. 1998).  Further increase in DDHR production 
could be achieved by genetic engineering or manipulation of the availability of precursors for 
synthesis of secondary metabolites (Martin et al. 2011; Martin and Liras 2010; Olano et al. 
2008). 
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Although polyenes are known as the first choice in antifungal treatment, their amphypatic 
structure allows functional versatility that cannot always be predicted - polyene macrolides such 
as nystatin and amphotericin B do not show any considerable antibacterial activity, but 
structurally related faeriefungin is active against gram positive, and some gram negative strains 
(Mulks et al. 1990).  Once we had established conditions for efficient production and isolation of 
DDHR, it allowed further detailed examination of its antibacterial properties.  With MICs higher 
than 400 μg ml-1 against bacterial strains, it was concluded that DDHR had no significant 
antibacterial effect.  However, MICs of 70 μg ml-1 against Candida albicans prompted further 
mechanistic studies.  MICs of other polyene antifungals against a range of Candida  albicans 
strains and clinical isolates vary greatly from 0.03 µg ml-1 for trichomycin (Komori 1990), 50 µg 
ml-1 for filipin (Hamilton-Miller 1973), 0.5 µg ml-1 to 1 mg ml-1 for amphotericin B (EUCAST 
2010), 0.54 µg ml-1 (Carrillo-Munoz et al. 1999; Arikan et al. 2002) and 5.29 µg ml-1 for nystatin 
(Sousa et al. 1985). 
 
To investigate the mechanism of DDHR induced cytotoxicity, we firstly examined the 
membrane integrity of DDHR treated RBCs.  Our results demonstrated that unlike natamycin 
which interferes with endocytosis but does not permeabilize (Van Leeuwen et al. 2009), or 
nystatin that induces apoptosis by forming transient pores in the membranes of treated cells, 
DDHR induces membrane damage since it causes dose dependent hemolysis.  In adition, we 
showed here that DDHR kills Candida cells by inducing membrane disruption since cell death 
was only observed in cells with damaged membranes.  The effect that DDHR has on cell 
membranes could be similar to structuraly similar filipin which forms micellar complexes with 
sterols that integrate into lipide bilayer changing its permeability and causing its disruption 
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(Aparicio et al. 2004).  However, the more detailed mechanistic studies have to be performed to 
elucidate the exact mechanism of how DDHR interacts with the membrane and causes its 
damage. 
Stodulkova et al. reported that DDHR colocalised with late endosomal / lysosomal markers in 
HeLa cells and induced apoptosis after 4 h of treatment with IC50 (concentration of the drug 
causing 50% inhibition of the cell viability) varying between 60 and 100 μM (Stodulkova et al. 
2011).  The cytotoxicity assay on fibroblast cell line presented here confirmed the cytotoxic 
effect of DDHR at relatively high concentrations (Fig. 5).  Polyenes bind membrane sterols 
whose presence influences the formation of pores and the effect that polyenes have on particular 
cell (Recamier et al., 2010).  Polyenes have higher affinity for ergosterol which is primarily 
constituent of fungal membranes while human cell membranes are richer in cholesterol (Teerlink 
et al. 1980).  This could explain the different effects of DDHR observed on mamalian in 
comparison to fungal cells.  In this sense DDHR should be developed in the direction of 
antifungal drugs not an antitumor agent as has been the case for other polyenes (Vaishnav and 
Demain 2011).  It was suggested that a possible approach in overcoming antifungal drug 
resistance was to combine two or three classes of antifungals preferrably the ones with different 
mechanisms of action (Vazquez, JA 2007).  Combination of DDHR with one of the antifungal 
drugs with different mode of action could be a good way for improvement of conventional 
antimycotic therapies making them more efficient and less toxic to human cells. 
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Supporting Information 
Figure S1. HPLC profile of ethylacetate extract of Streptomyces durmitorensis MS405 culture 
grown in NEM medium and (+)-HR ESI TOF MS of the most abundant compound of the extract 
(32,33- didehydroroflamycoin, DDHR). The adduct ions [M+Na]+ at m/z 759.3460 and 
[2M+Na]+ at m/z 1495.7045 could be observed. Also, a cluster of ions corresponding to the loss 
of water molecules (from two up to seven) from the molecular ion [M+H]+ were present. 
 
Figure legends 
Figure 1. 32,33-didehydroroflamycoin (DDHR) chemical structure (a) and characteristic 
polyene UV-Vis spectrum of the ethylacetate extract of the Streptomyces durmitorensis MS405 
submerged culture (b). 
Figure 2. Antibacterial properties of DDHR exhibited as zones of growth inhibition in disc 
diffusion assay against the panel of microorganisms. 
Figure 3. DDHR causes membrane damage. (a) One percent sheep RBCs were incubated with 
DDHR and hemolysis was followed by the increase of hemoglobin absorbance at 540 nm and 
quantified as percentage of Triton X-100 treated per total lysed cells. (b) Flourescent microscopy 
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of C. albicans treated for 2 h with DDHR or nystatin and stained with DAPI (blue) and PI (red). 
(c) FACS analysis of PI stained C. albicans treated with DDHR ( ; 50 or 100 µg ml-1, 
concentrations below or above MIC) or nystatin ( ; 5 or 10 µg ml-1, concentrations below or 
above MIC) for 2 h.  
Figure 4. Fluorescent microscopy of C. albicans cells treated with 25 µg ml-1 DDHR (a), 5 µg 
ml-1 nystatin (b) or combination of the two compounds- 25 µg ml-1 DDHR and 5 µg ml-1 nystatin 
(c) and stained with DAPI (blue) and PI (red). DMSO treated cells were presented as a negative 
control (d). 
Figure 5. Cytotoxicity (MTT) assay on human fibroblasts treated for 48 h with DDHR ( ) or 
nystatin ( ).  
 
Table 1. Biomass and DDHR accumulation by S. durmitorensis MS405 grown in different 
complex media at 30°C for 7 days. 
 
Mediuma CDW b, g l-1 DDHR, mg l-1 Productivity,  
mg DDHR mg CDW-1 
JS 20.3±0.7 108.6±0.8 5.3 
MSF 9.3±0.4 114.3±0.5 12.3 
NEM 5.2±0.3 211.4±0.2 40.6 
YED 3.7±0.6 nd c - 
GYM 2.8±0.5 nd - 
a Detailed composition of media are given in Materials and Methods section. 
b
 CDW= cell dry weight 
c
 not detected 
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Table 2 The effect of carbon source on DDHR production. 
a CDW= cell dry weight; Results are average of two different experiments. 
 
Table 3 Optimization of DDHR production in NEM medium. 
Optimization CDW a, g l-1 DDHR, mg l-1 Productivity, 
mg CDWg-1 
Subtraction of b    
mannitol  2.9 ndc - 
glucose  3.8 121.4 31.9 
YE 3.1 nd - 
ME 4.1 105.7 25.8 
CAA 3.4 101.4 29.8 
Supplementation with c    
methyl oleate (0.2%, v/v) 11.9 200.2 16.8 
grape seed oil (0.2%, v/v) 8.6 235.7 27.4 
a
 cell dry weight; 
b
 changes were made to NEM medium which composition is given in Materials and Methods section. 
c
 not detected; YE = yeast extract, ME = meat extract, CAA = casamino acids. The values are mean from 
two experiments. 
Carbon source CDW a, g l-1 DDHR, mg l-1 Productivity, mg CDWg-1 
glucose 2.7 22.9 8.5 
glycerol 5.4 60.1 11.1 
methyl oleate 7.4 201.4 27.2 
mannitol 6.3 215.7 34.2 
sodium succinate 5.2 nd b - 
arginine 4.5 nd - 
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